Gilead Sciences Inc (GILD) — Capital Reinvestment Ratio
Gilead Sciences Inc (GILD) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow ($4.11 Billion) in capital expenditures ($147.00 Million). See how leveraged is Gilead Sciences Inc's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Gilead Sciences Inc Capital Reinvestment Ratio (2002–2024)
This chart tracks Gilead Sciences Inc's Capital Reinvestment Ratio across 23 annual periods. Check cash flow reinvestment rate of Gilead Sciences Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Gilead Sciences Inc (2002–2024)
Year-by-year Capital Reinvestment Ratio for Gilead Sciences Inc from 2002 to 2024. For live market cap and broader valuation context, see Gilead Sciences Inc (GILD) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | $10.83 Billion | $523.00 Million | ▼ -33.9% |
| 2023 | 0.07x | $8.01 Billion | $585.00 Million | ▼ -8.9% |
| 2022 | 0.08x | $9.07 Billion | $728.00 Million | ▲ +57.8% |
| 2021 | 0.05x | $11.38 Billion | $579.00 Million | ▼ -36.1% |
| 2020 | 0.08x | $8.17 Billion | $650.00 Million | ▼ -11.8% |
| 2019 | 0.09x | $9.14 Billion | $825.00 Million | ▼ -18.0% |
| 2018 | 0.11x | $8.40 Billion | $924.00 Million | ▲ +121.8% |
| 2017 | 0.05x | $11.90 Billion | $590.00 Million | ▲ +13.0% |
| 2016 | 0.04x | $17.05 Billion | $748.00 Million | ▲ +24.8% |
| 2015 | 0.04x | $21.25 Billion | $747.00 Million | ▼ -19.1% |
| 2014 | 0.04x | $12.82 Billion | $557.00 Million | ▼ -29.0% |
| 2013 | 0.06x | $3.10 Billion | $190.00 Million | ▼ -50.8% |
| 2012 | 0.12x | $3.19 Billion | $397.00 Million | ▲ +242.8% |
| 2011 | 0.04x | $3.64 Billion | $131.90 Million | ▲ +66.0% |
| 2010 | 0.02x | $2.83 Billion | $61.88 Million | ▼ -70.8% |
| 2009 | 0.07x | $3.08 Billion | $230.06 Million | ▲ +39.2% |
| 2008 | 0.05x | $2.14 Billion | $115.00 Million | ▲ +20.4% |
| 2007 | 0.04x | $1.77 Billion | $78.65 Million | ▼ -48.4% |
| 2006 | 0.09x | $1.22 Billion | $105.21 Million | ▲ +27.1% |
| 2005 | 0.07x | $705.64 Million | $47.95 Million | ▼ -32.8% |
| 2004 | 0.10x | $507.96 Million | $51.37 Million | ▼ -38.6% |
| 2003 | 0.16x | $234.61 Million | $38.61 Million | ▼ -30.4% |
| 2002 | 0.24x | $74.41 Million | $17.60 Million | — |